RESEARCH COLLECTION / ACTOPROTECTORS

Actoprotector research

Drugs studied for preserving physical work capacity under stress, including the adamantane derivative Bromantane and the benzimidazole Bemitil.

Browse study findings by subject ↓

Filter Bemitil topics

Findings from selected studies

  • Bemitil during a sea voyage

    Of 298 maritime operators, 148 received Bemitil and 150 placebo. The paper reports 6.7% shorter simple reaction time and 13.7% greater static endurance. Detailed tests involved a subset of 20.

62 of 62 Bemitil topics

About the Bemitil topic map

Some publications cover several research topics. “Archive target” marks a citation whose original report is unavailable.

01 / Occupational & performance

Physical work capacity

Human report

Controlled-workload monograph material is linked as a starting point. It includes combination arms; it does not establish general enhancement or synergy.

02 / Occupational & performance

Combined extreme conditions

Human report

A combined heat/gas volunteer abstract and historical guidance are located. The English abstract has a monoxide/dioxide inconsistency; original methods remain necessary.

03 / Occupational & performance

Recovery after acute physical fatigue

Human report

Controlled-workload monograph material is linked as a starting point. It includes combination arms; it does not establish general enhancement or synergy.

04 / Occupational & performance

Chronic asthenic symptoms

Human report

Patient comparisons and pharmacokinetic correlations are recovered as indexed abstracts. Allocation, full outcomes and independent replication remain unresolved.

05 / Occupational & performance

Mental and operator workload

Human report

The voyage abstract reports operator measures. Kim’s combination research is a separate dissertation trail; its original methods remain pending.

06 / Occupational & performance

Historical military operations

Historical account

These sources describe operational history. Contemporary documents establishing the deployment details and treatment effects are unavailable.

Show 56 more Bemitil topics
07 / Occupational & performance

Long maritime voyages

Human report

The 1991 voyage abstract is distinct from the later naval teaching manual. Complete cohort and allocation details are still needed.

08 / Occupational & performance

Heat and overheating

Human report

A combined heat/gas volunteer abstract and historical guidance are located. The English abstract has a monoxide/dioxide inconsistency; original methods remain necessary.

09 / Occupational & performance

Altitude and hypoxia

Human report

Metaprot plus Ladasten was studied after ascent to high altitude. No isolated-component arm is described in the abstract; not a synergy or altitude-illness-prevention finding.

10 / Occupational & performance

Cold exposure

Archive target

The B-300 dissertation describes a combination. The original cold-adaptation proceedings would be needed to identify a Bemitil-only comparison.

11 / Occupational & performance

Antarctic wintering

Historical account

These sources describe operational history. Contemporary documents establishing the deployment details and treatment effects are unavailable.

12 / Occupational & performance

Sports recovery

Archive target

The original study and its methods are unavailable.

13 / Occupational & performance

Occupational noise and hearing-loss prevention

Patent report

A patent reports 148 noise-exposed workers in three unequal groups. Randomization, blinding and exposure comparability are not established.

14 / Occupational & performance

Sensorineural hearing loss

Archive target

Glaznikov’s hearing section concerns occupational hearing. Prevention and treatment of established hearing loss are distinct outcomes.

15 / Occupational & performance

Combined interventions for chronic hearing loss

Patent report

Patent combines Bemitil, dalargin and acupuncture. Case material does not isolate the effect of any component.

16 / Occupational & performance

Vestibular dysfunction

Archive target

The original study and its methods are unavailable.

17 / Occupational & performance

Statokinetic and operator resistance

Archive target

The original study and its methods are unavailable.

18 / Clinical research

Progressive muscular dystrophy

Human report

Small neuromuscular reports (21 and 22 patients) address biochemical changes. Cohort overlap and durable functional outcomes need checking.

19 / Clinical research

Myotonia and secondary amyotrophies

Human report

Related neuromuscular abstracts are linked. Specific myotonia and secondary-amyotrophy subgroup findings still require original reports; do not generalize progressive-dystrophy findings.

20 / Clinical research

Psychiatric and neurological asthenia

Human report

Patient comparisons and pharmacokinetic correlations are recovered as indexed abstracts. Allocation, full outcomes and independent replication remain unresolved.

21 / Clinical research

Chronic hepatitis

Human report

Human liver-cell measurements changed, but structural abnormalities persisted and measures did not normalize. This is not demonstrated reversal of liver disease.

22 / Clinical research

Hepatitis A rehabilitation

Archive target

The 1993 issue contains a hepatitis A rehabilitation citation lead. Original methods and clinical outcomes remain pending.

23 / Clinical research

Liver disease of different etiologies

Archive target

The original study and its methods are unavailable.

24 / Clinical research

Cirrhosis

Human report

Human liver-cell measurements changed, but structural abnormalities persisted and measures did not normalize. This is not demonstrated reversal of liver disease.

25 / Clinical research

Liver-associated immune dysfunction

Archive target

The original study and its methods are unavailable.

26 / Clinical research

Pneumonia combination research

Archive target

The original study and its methods are unavailable.

27 / Clinical research

Chronic respiratory failure

Archive target

The original study and its methods are unavailable.

28 / Clinical research

Acute myocardial infarction

Archive target

The original study and its methods are unavailable.

29 / Clinical research

Ischemic heart disease

Archive target

The original study and its methods are unavailable.

30 / Clinical research

Coronary artery bypass surgery

Archive target

A conference citation identifies the CABG report. The accessible record gives no study design or clinical outcome.

31 / Clinical research

Major surgery and hysterectomy

Archive target

The original study and its methods are unavailable.

32 / Clinical research

Fetal hypoxia and gestosis

Archive target

The pregnancy/gestosis lead remains unverified. No pregnancy safety or treatment recommendation is supported here.

33 / Occupational & performance

Emergency responders

Historical account

Recovered historical guidance is not a contemporary safety standard or a controlled emergency-response trial.

34 / Occupational & performance

Chernobyl rehabilitation

Dissertation context

An author’s abstract discusses rehabilitation after Chernobyl. Full clinical methods and the earlier Yagupov report remain pending; this is not proof of radioprotection.

35 / Occupational & performance

Armenian earthquake response

Historical account

These sources describe operational history. Contemporary documents establishing the deployment details and treatment effects are unavailable.

36 / Mechanisms & preclinical

Acute hypoxic hypoxia

Animal / laboratory

Rat pressure-chamber experiments measured glutathione-related biochemical responses. These endpoints do not establish human hypoxia protection.

37 / Mechanisms & preclinical

Glutathione systems

Animal / laboratory

Rat pressure-chamber experiments measured glutathione-related biochemical responses. These endpoints do not establish human hypoxia protection.

38 / Mechanisms & preclinical

Lipid peroxidation

Human report

A small neuromuscular patient study examined lipid peroxidation and erythrocyte membranes. Biomarker change is not a general clinical benefit.

39 / Mechanisms & preclinical

Antioxidant enzymes

Animal / laboratory

Rat pressure-chamber experiments measured glutathione-related biochemical responses. These endpoints do not establish human hypoxia protection.

40 / Mechanisms & preclinical

Brain responses to hypoxia

Animal / laboratory

Rat intermittent-hypoxia work links brain metabolic measures to the experimental adaptation model.

41 / Mechanisms & preclinical

Cerebral hemorrhage models

Archive target

The original study and its methods are unavailable.

42 / Mechanisms & preclinical

Seizure models

Archive target

The original study and its methods are unavailable.

43 / Mechanisms & preclinical

Central nervous system trauma

Archive target

The original study and its methods are unavailable.

44 / Mechanisms & preclinical

Myocardial ischemia models

Archive target

The original study and its methods are unavailable.

45 / Mechanisms & preclinical

Reperfusion models

Archive target

The original study and its methods are unavailable.

46 / Mechanisms & preclinical

Acute heart-failure models

Archive target

The original study and its methods are unavailable.

47 / Mechanisms & preclinical

Intestinal ischemia and shock

Archive target

The original study and its methods are unavailable.

48 / Mechanisms & preclinical

Peritonitis and mucosal repair

Archive target

The original study and its methods are unavailable.

49 / Mechanisms & preclinical

Liver regeneration after hepatectomy

Archive target

The original study and its methods are unavailable.

50 / Mechanisms & preclinical

Toxic liver injury

Dissertation context

An author’s abstract describes toxic-injury experiments. Model-specific results do not validate human antidote combinations or self-treatment.

51 / Mechanisms & preclinical

PCB and ethanol liver-injury models

Dissertation context

An author’s abstract describes toxic-injury experiments. Model-specific results do not validate human antidote combinations or self-treatment.

52 / Mechanisms & preclinical

Organophosphate injury models

Dissertation context

An author’s abstract describes toxic-injury experiments. Model-specific results do not validate human antidote combinations or self-treatment.

53 / Mechanisms & preclinical

Dichloroethane injury models

Archive target

The original study and its methods are unavailable.

54 / Mechanisms & preclinical

Ethylene glycol injury models

Archive target

The original study and its methods are unavailable.

55 / Mechanisms & preclinical

Nitrite injury models

Dissertation context

An author’s abstract describes toxic-injury experiments. Model-specific results do not validate human antidote combinations or self-treatment.

56 / Mechanisms & preclinical

Red-cell recovery

Archive target

The original study and its methods are unavailable.

57 / Mechanisms & preclinical

Membrane stability

Human report

A small neuromuscular patient study examined lipid peroxidation and erythrocyte membranes. Biomarker change is not a general clinical benefit.

58 / Mechanisms & preclinical

Bronchopulmonary inflammation models

Archive target

The original study and its methods are unavailable.

59 / Mechanisms & preclinical

Immune and inflammatory models

Archive target

The original study and its methods are unavailable.

60 / Safety & metabolism

Gonadal adverse effects

Animal / laboratory

Prolonged exposure reduced sexual activity and a spermatogenesis measure in rats. This is a safety signal requiring follow-up, not human risk quantification.

61 / Safety & metabolism

Pregnancy and development in animals

Archive target

Original Bemitil developmental studies are still needed. Bromantane developmental findings must not be transferred to Bemitil.

62 / Safety & metabolism

CYP450 and drug metabolism

Animal / laboratory

Rat enzyme induction, cultured human lymphocytes and rat-urine metabolite analysis concern metabolism. They do not establish safe human interactions.

Educational only. Not medical advice. Seek qualified healthcare help for any medical condition. Historical proposals, patents and experimental models are not personal treatment recommendations.

Updated evidence, original methods and remaining gaps ↗

BROMANTANE × BEMITIL / RESEARCH CONTEXTS

Bromantane and Bemitil: evidence comparison

Research comparisons and proposed contexts, not recommended combinations
Compound / formulationContextSource typeInterpretation limits
Ladasten + SydnocarbAnimal swimming performance and heat exposureSeparate experimental reports, 2006Source record ↗Single drugs outperformed the combination in swimming; a separate heat study was favorable. Effects are model-specific, not evidence of universal synergy.
Bromantane / LadastenPatient asthenia versus rested or fatigued volunteersRandomized patient trial, uncontrolled multicenter report and small laboratory comparisonsSource record ↗Clinical symptoms and performance measures answer different questions. Duplicate multicenter reports are grouped.
Bemitil / MetaprotAsthenia, neuromuscular and occupational researchHuman reports, patent-reported hearing comparison, animal and metabolism studiesSource record ↗Full methods and independent replication remain uneven. Biomarker changes are not proven clinical recovery.
Bemitil + BromantaneCombined heat/gas exposure1993 volunteer comparison plus 1996 guidanceSource record ↗The abstract has a monoxide/dioxide translation inconsistency. Historical findings are not exposure-safety guidance.
Metaprot + LadastenShort-term high-altitude adaptation2014 volunteer comparison with hypoxen and placeboSource record ↗No isolated-component arms described; neither synergy nor altitude-illness prevention established.
BromitilCombined-tablet pharmacokinetics2009 dissertation abstract; animal experimentsSource record ↗Formulation identity is documented there. Current product equivalence, human benefit and safe ratios are not established.

Trekrezan in rat endurance and muscle assays

A 60-rat patent experiment reported loaded swim times of 33.50 minutes with saline and 48.00 and 52.30 minutes with 10 and 25 mg/kg Trekrezan. The same filing reports PGC‑1α and mitochondrial DNA measurements.

Patent methods and all arm results ↗ · Trekrezan research profile ↗

Assessing the evidence

Reports are not independent trials

The Ladasten multicenter reports share the same cohort description. The small Bemitil neuromuscular papers may overlap. Bibliography length is not a measure of replicated effectiveness.

A patent is a different source

The occupational hearing comparison is a patent-reported cohort. The Ladasten patent documents a proposed new use of Bromantane. Neither patent status nor publication establishes clinical efficacy.

Sources to locate or review

Dissertation abstracts, indexed abstracts, original text and unlocated documents have explicit labels. Claims about heat protection, military deployment and emergency use require supporting original documents.

BIBLIOGRAPHY / FOUNDATIONS & OPEN TARGETS

Additional archival references

Source-linked studies appear on the compound profiles and in the main bibliography. These additional records include dissertations, books, patents and proceedings—including documents that remain unrecovered.

1993

Substituted N-adamantylamines — author’s certificate 860446

Earlier certificate cited by a recovered patent; original pending

Cited in the original Ladasten patent. The proposed 21 April 1980 priority date awaits the original certificate; publication and invention dates must not be conflated.

Bibliography record ↗
DATE UNRESOLVED

Adamantane precursors: ADK-638, ADK-910 and ADK-918

Archive target · original not recovered

ADK-638, Chlodantane and the benzamide compounds belong to distinct branches. Certificate 740752 and papers from 1979 and 1986 are cited in accounts of their development.

Bibliography record ↗
1984

Pharmacokinetics of Bromantane

Archive target · original not recovered

A later author bibliography cites S. A. Medvedkova, Moscow 1984, 19 pages; the earlier G. A. initials conflict. Authenticate the original catalogue before entering pharmacokinetic estimates.

Bibliography record ↗
1993

Mechanisms of action of adamantane derivatives with protective effects under extreme conditions

Archive target · original not recovered

The dissertation citation gives no original methods, population or comparator tables.

Bibliography record ↗
1997

Mechanisms of stress-protective action of Bromantane and Chlodantane

Library catalogue verified; original scan appraisal pending

Russian State Library record 01000029984 confirms A. R. Khalimov, Ufa 1997, 22 pages; the earlier Yu. Sh. attribution was incorrect. Original scan appraisal and endocrine findings remain unresolved.

Bibliography record ↗
DATE UNRESOLVED

Pharmacological correction of operator-skill learning during intense physical workload

Archive target · original not recovered

Unverified lead comparing piracetam, Bemitil and Bromantane. The reported July 1994 instruction and later Captain NEMO / Yagupov links require original documents.

Bibliography record ↗
2007

Mechanisms of Ladasten’s psychostimulant, anxiolytic and immunotropic activity

Author’s abstract · Russian transcription and PDF link

Author’s abstract and its associated mechanistic program located. The 44-page abstract is not the complete 336-page dissertation. Rat-brain and cell findings do not establish human clinical effects.

Bibliography record ↗
2001

Pharmacology of Adamantanes

Book cited by recovered patent; book not recovered

The Ladasten formulation patent cites this book as historical background. The patent does not describe a trial from the book.

Bibliography record ↗
1995

Study of heat-protective effects of Bromantane at various levels of overheating

Publisher page with PDF link · PDF not yet inspected

Publisher page offers the original Russian PDF. Indexed abstract checked; original heat protocols and ambiguous English wording still need appraisal. This is the same source as PMID 7793100, not another study.

Bibliography record ↗
1984

Bemitil: Main Results of Clinical Study and Prospects for Use

Archive target · original not recovered

The proceedings and the Bobkov–Vinogradov recommendations are identifiable from citations. The individual study designs remain uncertain.

Bibliography record ↗
1984

Pharmacological Correction of Fatigue

Archive target · original not recovered

The book and Smirnov mechanism chapter remain acquisition targets. Full bibliographic transcription and original chapter retrieval remain pending.

Bibliography record ↗
1993

Bemitil dossier — Physiologically Active Substances, issue 25

Archive target · original not recovered

The issue covers mechanisms, operator workload, neuromuscular disease, occupational hearing, hepatitis A and intestinal ischemia. Page numbers differ between citations.

Bibliography record ↗
1994

Antihypoxants and Actoprotectors: Results and Prospects

Archive target · original not recovered

CABG, pediatric croup and other clinical leads trace to proceedings. Original reports, enrollment, allocation and outcomes remain unresolved.

Bibliography record ↗
DATE UNRESOLVED

Naval, Antarctic and emergency-response Bemitil records

Archive target · original not recovered

Archival leads include 1993 naval chapters, 1996 Marine Medical Journal, Antarctic wintering and Chernobyl rehabilitation. Operational use narratives are not controlled efficacy evidence. See the separately linked 1991 voyage study and recovered scan, 2015 naval manual and 1996 rescue guidance.

Bibliography record ↗
DATE UNRESOLVED

Broader clinical Bemitil archive: liver, heart, lungs, surgery and pregnancy

Archive target · original not recovered

Preserves the reported clinical leads without turning them into established indications. This includes gestosis/fetal hypoxia, major surgery, respiratory failure and rehabilitation; no pregnancy or condition-specific safety conclusion follows.

Bibliography record ↗
DATE UNRESOLVED

Bemitil preclinical archive: ischemia, poisoning, repair and reproductive effects

Archive target · original not recovered

Targets include cerebral and myocardial injury, intestinal ischemia, peritonitis, hepatectomy, convulsions, chemical exposures and developmental toxicology. Models and formulations must be checked separately; class-level findings cannot be assigned to Bemitil automatically.

Bibliography record ↗
2009

New approaches to pharmacological correction of nonspecific components of toxic injury

Author’s abstract · Russian web transcription

Author’s abstract transcription identifies Bromitil as a combined Bromantane–Bemitil tablet studied in animals, and describes toxic-injury and Chernobyl-rehabilitation work. OCR has an inconsistent title-page year; metadata and defense text indicate 2009. Complete thesis and raw data not reviewed.

Bibliography record ↗
2004

Bemitil, dalargin and acupuncture for chronic sensorineural hearing loss — RU2223741C1

Patent text located · individual case descriptions

Patent describes a multi-component intervention and case material. It cannot isolate Bemitil’s effect. Separate from Glaznikov’s occupational-noise prevention patent.

Bibliography record ↗
2010

Ladasten multicenter report — related record PMID 21322821

English abstract · related cohort report

Same title, 28-center / 728-patient cohort and abstract as PMID 20559263. Retained as a related publication, not an additional independent trial.

Bibliography record ↗

Study findings by subject

119 source records

2010 · Animal research

[Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamines and their metabolites in the brain structures of Wistar rat on the model of monoamine synthesis blockade induced by aromatic amino acid decarboxylase inhibitor NSD-1015].

Under experimental blockade of monoamine synthesis, Ladasten increased L-DOPA in several rat brain regions and altered dopamine-metabolism indices. Effects differed from the afobazole comparator.

Afobazole-only serotonin changes · 5-HT up to +50%, precursor up to +60%, metabolite up to +50% · These percentages are NOT Ladasten effects

Methods and source ↗ · Bromantane